David I. Sandoval, General Counsel at MaxCyte, Inc. (MXCT), made one open market sale of MXCT shares in the last 365 days, totaling about $1,122. His most recent sale occurred on March 18, 2025. These sales rank 11,542nd among 11,678 individual insiders, compared to an average sale amount of $8.6 million across 6.37 transactions per insider. Sandoval had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2025 | MAXCYTE, INC. | $MXCT | Sandoval David I. | GENERAL COUNSEL | S | Common Stock | 353 | $3.18 | 64,219.0000 | 104,849,222 | 0.55% | 0.00% |
| March 14, 2025 | MAXCYTE, INC. | $MXCT | Sandoval David I. | GENERAL COUNSEL | A | Common Stock | 23125 | $0.00 | 64,572.0000 | 104,849,222 | 55.79% | 0.02% |
| March 14, 2025 | MAXCYTE, INC. | $MXCT | Sandoval David I. | GENERAL COUNSEL | A | Employee Stock Option (right to buy) | 92500 | $0.00 | 92,500.0000 | 104,849,222 | 9999.99% | 0.09% |
| Jan. 13, 2025 | MAXCYTE, INC. | $MXCT | Sandoval David I. | GENERAL COUNSEL | S | Common Stock | 4466 | $4.54 | 41,447.0000 | 104,849,222 | 9.73% | 0.00% |
| March 15, 2024 | MAXCYTE, INC. | $MXCT | Sandoval David I. | GENERAL COUNSEL | A | Common Stock | 3913 | $0.00 | 45,913.0000 | 103,268,502 | 9.32% | 0.00% |
| March 15, 2024 | MAXCYTE, INC. | $MXCT | Sandoval David I. | GENERAL COUNSEL | A | Employee Stock Option (right to buy) | 15625 | $0.00 | 15,625.0000 | 103,268,502 | 9999.99% | 0.02% |